SCHEMBL3637549

SCHEMBL3637549

CN1CCN(C(C(=O)O)c2ccccn2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 1/20 0.50
BAX Q07812 1/20 0.48
MAPT P10636 2/20 0.47
NPC1 O15118 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
SLC1A3 P43003 1/20 0.46
HTT P42858 2/20 0.45
LMNA P02545 2/20 0.45
ALDH1A1 P00352 2/20 0.45
KDM4E B2RXH2 2/20 0.45
HSP90AA1 P07900 1/20 0.45
PPP1CA P62136 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
KCNA5 P22460 3/20 0.44
KCNE1 P15382 1/20 0.44
SLC1A2 P43004 1/20 0.44
MC4R P32245 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
CHRM2 P08172 1/20 0.42
CHRM4 P08173 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30499312 0.87 IDH1 (0.49) IDH1BAXMAPTNPC1TDP1
SCHEMBL2555289 0.86 KCNA5 (0.60) MAPTTDP1HTTLMNAALDH1A1
Hydrochloric Acid SCHEMBL2547992 0.85 LMNA (0.61) MAPTTDP1HTTLMNAALDH1A1
SCHEMBL30499284 0.82 KCNA5 (0.46) IDH1BAXMAPTNPC1TDP1
SCHEMBL13044658 0.82 GAA (0.52) IDH1BAXMAPTNPC1TDP1
SCHEMBL30505194 0.82 SLC6A4 (0.47) LMNAALDH1A1KDM4EL3MBTL1KCNA5
SCHEMBL11813355 0.81 IDH1 (0.49) IDH1BAXMAPTNPC1TDP1
SCHEMBL3635844 0.80 CCR1 (0.40) IDH1BAXMAPTNPC1TDP1
SCHEMBL13044640 0.79 GPR119 (0.51)
SCHEMBL3633189 0.78 HTR3E (0.45) IDH1BAXMAPTNPC1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed
EP-2167466-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR Glaxo Group Limited (GB) 2010-03-31 EP disclosed
WO-2008148853-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2008-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GIPR, GHSR, GLP1R IDH1 2957/4885BAX 1311/4885MAPT 4184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.